CStone Pharmaceuticals' share capital remains steady in October

CStone Pharmaceuticals reported no changes to its authorized or issued share capital for the month ended October 31, 2025. The company's total authorized share capital remained at $200,000, with 2,000,000,000 ordinary shares, each with a par value of $0.0001.

The number of issued ordinary shares also held steady at 1,475,977,923. No new shares were issued, nor were any treasury shares transferred during the month. The company’s Pre-IPO Incentivization Plan had 1,175,618 options outstanding, with no movement reported in October.

Under the Post-IPO Employee Share Option Plan, 71,549 options lapsed, bringing the total outstanding options to 90,465,225. The total number of shares that may be issued upon exercise of all share options under this scheme stands at 45,182,001. No funds were raised from the exercise of options during the month.